Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

ALT-946

Known as: N-(2-acetamidoethyl)hydrazinecarboximidamide 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2015
Review
2015
CONTEXT Advanced Glycation End-Products (AGEs) are signaling proteins associated to several vascular and neurological… Expand
  • table 1
  • table 2
Is this relevant?
2006
2006
Despite over half a century of intensive research, cardiovascular disease remains the leading cause of death worldwide. A number… Expand
Is this relevant?
Review
2006
Review
2006
The morbidity caused by diabetes has traditionally been classified into macro- and microvascular complications. Although… Expand
  • figure 1
  • table 1
Is this relevant?
Review
2005
Review
2005
Prolonged hyperglycemia, dyslipidemia and oxidative stress in diabetes result in the production and accumulation of AGEs. It is… Expand
Is this relevant?
Highly Cited
2002
Highly Cited
2002
The severe diabetic nephropathy that develops in the hypertensive transgenic (mRen-2)27 rat with streptozotocin (STZ) diabetes… Expand
  • figure 1
  • table 1
  • figure 2
  • figure 3
  • figure 4
Is this relevant?
Highly Cited
2001
Highly Cited
2001
Aims/hypothesis. ALT-946, an inhibitor of advanced glycation with a minimal inhibitory effect on nitric oxide synthase, was… Expand
Is this relevant?